← FDA Drug Approvals (Drugs@FDA)
RASAGILINE MESYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2013-07-01
Drug application
- FDA Application #
ANDA201823- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RASAGILINE MESYLATE
- Generic name
- Rasagiline Mesylate
- Active ingredients
- RASAGILINE MESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- WATSON LABS INC
- First approval
- 2013-07-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown